Cargando…
Clinical Advances and Perspectives in Targeted Radionuclide Therapy
Targeted radionuclide therapy has become increasingly prominent as a nuclear medicine subspecialty. For many decades, treatment with radionuclides has been mainly restricted to the use of iodine-131 in thyroid disorders. Currently, radiopharmaceuticals, consisting of a radionuclide coupled to a vect...
Autores principales: | Lepareur, Nicolas, Ramée, Barthélémy, Mougin-Degraef, Marie, Bourgeois, Mickaël |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303056/ https://www.ncbi.nlm.nih.gov/pubmed/37376181 http://dx.doi.org/10.3390/pharmaceutics15061733 |
Ejemplares similares
-
Antibody-Hapten Recognition at the Surface of Functionalized Liposomes Studied by SPR: Steric Hindrance of Pegylated Phospholipids in Stealth Liposomes Prepared for Targeted Radionuclide Delivery
por: Botosoa, Eliot. P., et al.
Publicado: (2011) -
Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy
por: Eychenne, Romain, et al.
Publicado: (2020) -
Targeted Radionuclide Therapy
por: Ersahin, Devrim, et al.
Publicado: (2011) -
Targeted Radionuclide Therapy of Prostate Cancer—From Basic Research to Clinical Perspectives
por: Czerwińska, Malwina, et al.
Publicado: (2020) -
Development of Biocompatible and Functional Polymeric Nanoparticles for Site-Specific Delivery of Radionuclides
por: Lepareur, Nicolas, et al.
Publicado: (2015)